6 results Financial Regulatory – Update Q1 2021 Traditionally, 1 January (and 1 July) each year is a date on which new Dutch financial regulations enter into force. This year, the amendments to the Dutch Financial Supervision Act are relatively few, but other developments are worthy of attention. Nicolas Pradel Senior Associate Luxembourg Stibbe advises Dyme Stibbe has advised fintech company Dyme on obtaining a PSD2 licence for the provision of Account Information Services (AIS) from the Dutch Central Bank. Dyme is the first independent payment service for consumers in the Netherlands to receive this licence Stibbe advises SleepScore Labs Stibbe advised SleepScore Labs on the acquisition of Sleep.ai, a Netherlands-based digital health company. Legal Considerations for Artificial Intelligence in the Life Sciences Sector This blogpost explores the evolving legal landscape governing AI in life sciences, with a focus on medical device regulation, data protection and intellectual property. DNB's AI Guidance: balancing innovation with prudence The Dutch Central Bank (De Nederlandsche Bank, DNB) has shared new key considerations on the use of artificial intelligence in the insurance sector.
Financial Regulatory – Update Q1 2021 Traditionally, 1 January (and 1 July) each year is a date on which new Dutch financial regulations enter into force. This year, the amendments to the Dutch Financial Supervision Act are relatively few, but other developments are worthy of attention.
Stibbe advises Dyme Stibbe has advised fintech company Dyme on obtaining a PSD2 licence for the provision of Account Information Services (AIS) from the Dutch Central Bank. Dyme is the first independent payment service for consumers in the Netherlands to receive this licence
Stibbe advises SleepScore Labs Stibbe advised SleepScore Labs on the acquisition of Sleep.ai, a Netherlands-based digital health company.
Legal Considerations for Artificial Intelligence in the Life Sciences Sector This blogpost explores the evolving legal landscape governing AI in life sciences, with a focus on medical device regulation, data protection and intellectual property.
DNB's AI Guidance: balancing innovation with prudence The Dutch Central Bank (De Nederlandsche Bank, DNB) has shared new key considerations on the use of artificial intelligence in the insurance sector.